Prescription medication advertising: Professional discomfort and potential patient benefits–can the two be balanced?

International Journal of Advertising

Volumn 23, Issue 1, 2004, Pages 69-90

  Eagle, Lynne ^a   Chamberlain, Kerry ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745959091     PISSN: 02650487     EISSN: None     Source Type: Journal    
DOI: 10.1080/02650487.2004.11072873     Document Type: Article

References (53)

1. ACNielsen (2003) Estimated Advertising Expenditure. Nielsen Media Research Services, Auckland, ACNielsen.
2. Advertising Standards Authority (2000) Proposal for Self-regulation of Internet Marketing. http://www.asa.co.nz/proposal.htm, accessed 7 September 2000.
3. Anon (1998) Doctor, doctor. Let advertisers tell Europe’s patients more about drugs. The Economist, 348(8080), 8 August, p. 18.
4. Anon (2002) Europe on the brink of direct-to-consumer drug advertising. The Lancet, 359(9319), 18 May, p. 1709.
5. Bell, R.A., Kravitz, R.L. & Wilkes, M.S. (1999) Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14(11), pp. 651–657.
6. Berndt, E.R. (2001) The U.S. pharmaceutical industry: why major growth in times of cost containment? Health Affairs, 20(2), pp. 100–114.
7. Brekke, K.R. & Kuhn, M. (2002) The Effect of DTC Advertising in Pharmaceutical Markets. University of York, England: Centre for Health Economics.
8. Brichacek, A. (2000) DTC strategies target compliance. Pharmaceutical Executive, 20(12), December, pp. 74–75.
9. Calfee, J.E. (2002) Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21(2), pp. 174–193.
10. Cohodes, D.R. (1995) Through the looking glass: decision making and chemotherapy. Health Affairs, 14(4), pp. 203–206.
11. Cozens, C. (2002) Europe rejects drug advertising. Guardian, 23 October. Online edition: http://www.baumhedlundlaw.com/media/ssri/paxil/GuardianUnlimited.htm, accessed 11 November 2002.
12. Desselle, S.P. & Aparasu, R. (2000) Attitudinal dimensions that determine pharmacists decisions to support DTC of prescription medication. Drug Information Journal, 34(1), pp. 103–114.
13. Driscoll, B. (2001) The internet and prescription medicines: a legal minefield? International Journal of Medical Marketing, 1(4), pp 319–325.
14. Eagle, L.C. & Kitchen, P.J. (2002) Direct consumer promotion of prescription drugs: a review of the literature and the New Zealand experience. International Journal of Medical Marketing, 2(4), pp. 293–310.
15. Food and Drug Agency (FDA) (1999, 2000, 2002) Direct to Consumer Advertising Surveys. Washington DC: Food and Drug Agency. Division of Drug Marketing, Advertising and Communications.
16. Findlay, S.D. (2001) Direct-to-consumer promotion of prescription drugs. economic implications for patients, payers and providers. Pharmoeconomics, 19(2), pp. 109–119.
17. Frederick, J. (1998) Aging boomers, new medicines draw men into spotlight. Drug Store News, 20(11), pp. 24–27.
18. Friedewald, V.E. (2000) The internet’s influence on the doctor–patient relationship. Health Management Technology, 21(11), November, pp. 79–80.
19. Glass, N. (2001) European Commission may reform drug advertising legislation. The Lancet, 358(9278), 28 July, p. 306.
20. Haynes, R.B., McDonald, H.P. & Garg, A.X. (2002) Helping patients follow prescribed treatment. Journal of the American Medical Association, 288(22), pp. 2880–2883.
21. Health Action International (HAI) (2002a) Providing prescription medicine information to consumers: is there a role for direct-to-consumer promotion? Symposium Report, Health Action International. www.hai.com, accessed 2 December 2002.
22. Health Action International (HAI) (2002b) The Erice Statement on Drug Advertising to Consumers. www.haiweb.org/campaign/DTC/EriceStatement2002.doc, accessed 2 December 2002.
23. Hutchins, T. (1999) In-pharmacy marketing. The next DTC/DTP frontier. Expose: Pharmacy Diagnostics, online edition http://www.ecrm-epps.com, accessed 19 November 2001.
24. Johnson, G.L. & Ramaprasad, A. (2000) Patient–physician relationships in the information age. Marketing Health Services, 20(1), Spring, pp. 21–27.
25. Kleinke, J.D. (2001) The price of progress: prescription drugs in the health care market. Health Affairs, 20(5), Sept./Oct., pp. 43–60.
26. Korcok, M. (2002) DTC ads in US having huge impact on drug sales, CMAJ, 167(3), 6 August, p. 289.
27. Levins, I. (1998) One-on-one relationship marketing comes of age. Medical Marketing & Media, 33(6), June, pp. 44–50.
28. Liebman, M. (1998) DTC programs spur compliance. Medical Marketing & Media, 33(11), November, pp. 58–61.
29. Lowes, R. (2000) Doctors and the web. Are online pharmacies good for your patient–and for you? Medical Economics, 77(11) 5 June, pp. 77–86.
30. Lyles, A. (2002) Direct marketing of pharmaceuticals to consumers. Annual Review of Public Health, 23(1), pp. 73–91.
31. MacKay, P. (2000) Pharmaceutical advertising–as seen on TV. New Zealand Medical Association Newsletter, Issue 236, 12 May, pp. 1–2.
32. Maling, N. (2000) Government orders drug ad review. Sunday Star Times, 8 October, p. A4.
33. McCarthy, R. (1998) The price you pay for the drug not taken. Business & Health, October, pp. 27–33.
34. Mechanic, D. (1997) Muddling through elegantly: finding the proper balance in rationing. Health Affairs, 16(5), Sept./Oct., p. 83.
35. Medawar, C. (1998) Advertising prescription-only drugs. The Lancet, 351(9115), 23 May, p. 1584.
36. Ministry of Health (2001) Health Report: Direct to Consumer Advertising of Prescription Medicines. 16 August. http://www.executive.govt.nz/minister/king/dtca/01.htm, accessed 12 December 2002.
37. Morgan, O.J. (1997) Self regulation of advertising, in Skinnon, J. & McDermott, J. (eds), The Law of Marketing In New Zealand. Lower Hutt: TOPNZ.
38. National Institute for Health Care Management (NIHCM) (2001) Prescription Drugs and Mass Media Advertising, 2000. Washington DC: The National Institute for Health Care Management.
39. Petersen, C. (1999) If you want to help asthma patients, treat their minds. Managed Healthcare, 9(4), April, pp. 40–43.
40. Pratt, P. (2002) Personal correspondence 20 December 2002 regarding NZ therapeutic products self-regulatory system effectiveness, from team leader (Compliance), Medsafe, Public Health Directorate, Ministry of Health.
41. Researched Medicines Industry (2000) DTC Advertising Can Enhance Public Health, http://www.nzhealthco.nz/rmi, accessed 7 September 2000.
42. Royal New Zealand College of General Practitioners. (2000) General practitioners have welcomed the Minister of Health’s decision to review direct-to-consumer (DTC) advertising. Press release, 9 October 2000.
43. Salisbury, P. (1943) Has advertising come of age? The Journal of Marketing, 8(1), pp. 25–32.
44. Siegel, L. (2000) DTC advertising: bane or blessing? A 360 degree view. Pharmaceutical Executive, 20(10), October, pp. 140–152.
45. Slaughter, E. (2002) 5th Annual Survey of Consumer Reaction to DTC Advertising of Prescription Medicines. Emmaus, PA: Rodale Inc.
46. Stanberry, B.A. (2002) Commentary: legal aspects of health on the internet: a European perspective. British Medical Journal, 324(7337), 9 March, pp. 605–606.
47. Spurgeon, D. (1999) Doctors feel pressured by direct to consumer advertising. British Medical Journal (online), 319, 20 November, www.bmj.com, accessed 30 October 2000.
48. Sullivan, D.L., Schomer, J.C. & Birdwell, S.W. (1999) Consumer retention of risk information from direct-to-consumer advertising. Drug Information Journal, 37(1), pp. 281–289. Online edition: www3.diahom.org, accessed 10 February 2003.
49. Toop, L., Dowell, A. & Tilyard, M. (2002) Important Issue, Please Read. Covering letter for survey of New Zealand doctors regarding DTC advertising.
50. Wade, J.C. (1995) The patient/doctor relationship: one doctor’s view. Health Affairs, 14(4), pp. 209–212.
51. Wang, J.C. (1999) Beyond DTC: what to do if FDA scales back DTC advertising. Pharmaceutical Executive, 19(7), July, pp. 58–60.
52. Weiss, G.B. (1985) Paternalism modernised. Journal of Medical Ethics, 11(4), pp. 184–187.
53. Wilkes, M.S., Bell, R.A. & Kravitz, R.L. (2000) Direct to consumer prescription drug advertising: trends, impacts and implications. Health Affairs, 19(2), pp. 110–128.